Inhalerx Ltd
Nexalis Therapeutics Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. It is developing IRX-211 that has completed Phase 1 clinical trial for the treatment of Breakthrough Cancer Pain (BTcP); and IRX-616a that is in preclinical trial for panic disorder (PD). The company was formerly known as InhaleRx Limited and changed its name Nexali… Read more
Inhalerx Ltd (IRX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.044x
Based on the latest financial reports, Inhalerx Ltd (IRX) has a cash flow conversion efficiency ratio of -0.044x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$38.91K) by net assets (AU$-877.11K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Inhalerx Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Inhalerx Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Inhalerx Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inhalerx Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Serrano Resources Ltd
PINK:MIRXF
|
-0.001x |
|
Key Alliance Group Bhd
KLSE:0036
|
1.195x |
|
Winchester Energy Ltd
AU:WEL
|
-0.014x |
|
Khind Holdings Bhd
KLSE:7062
|
-0.061x |
|
Glory Forever PCL
BK:GLORY
|
0.013x |
|
Norstar
TA:NSTR
|
0.014x |
|
Argent Minerals Limited
PINK:ARDNF
|
-0.530x |
|
Cahaya Bintang Medan Tbk Pt
JK:CBMF
|
0.000x |
Annual Cash Flow Conversion Efficiency for Inhalerx Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Inhalerx Ltd from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$-63.97K | AU$-368.77K | 5.765x | +295.55% |
| 2023-12-31 | AU$665.47K | AU$-1.96 Million | -2.948x | -203.82% |
| 2022-12-31 | AU$1.90 Million | AU$-1.85 Million | -0.970x | -126.23% |
| 2021-12-31 | AU$2.68 Million | AU$-1.15 Million | -0.429x | +47.70% |
| 2020-12-31 | AU$1.32 Million | AU$-1.09 Million | -0.820x | +85.05% |
| 2019-12-31 | AU$340.08K | AU$-1.87 Million | -5.487x | -613.06% |
| 2018-12-31 | AU$2.68 Million | AU$-2.06 Million | -0.770x | -35.45% |
| 2017-12-31 | AU$4.51 Million | AU$-2.56 Million | -0.568x | -1717.88% |
| 2016-12-31 | AU$7.33 Million | AU$-229.03K | -0.031x | -- |